Technetium99m sestamibi myocardial perfusion imaging predicts clinical outcome in the community outpatient setting: The Nuclear Utility in the Community (NUC) Study

Journal of the American College of Cardiology

Volumn 43, Issue 2, 2004, Pages 213-223

  Thomas, Gregory S ^a   Miyamoto, Michael I ^a   Morello III, A Peter ^a   Majmundar, Haresh ^a   Thomas, Jennifer J ^a   Sampson, Christine H ^a   Hachamovitch, Rory ^b   Shaw, Leslee J ^c  

^a Mission Internal Medical Group   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Atlanta Cardiovasc Res Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; THALLIUM;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; COMMUNITY CARE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DEMOGRAPHY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; ELECTROCARDIOGRAM; EVALUATION; EXERCISE; EXERCISE TEST; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART FUNCTION TEST; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; HUMAN EXPERIMENT; IMAGING SYSTEM; LABORATORY; MALE; METHODOLOGY; MULTIVARIATE ANALYSIS; NUCLEAR MEDICINE; OUTPATIENT; PATIENT REFERRAL; PHARMACOLOGY; PREDICTION; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REGRESSION ANALYSIS; REST; REVASCULARIZATION; RISK ASSESSMENT; SCINTISCANNING; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS; SURVIVAL; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; UTILIZATION REVIEW; VASODILATATION;

EID: 1042275867     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.07.041     Document Type: Article

References (40)

1. Nuclear Medicine Market Summary Report 2001-02. Des Plaines, IL: IMV Medical Information Division.
2. Nuclear Medicine Market Summary Report 1991-92. Des Plaines, IL: Technology Marketing Group.
3. Brown K.A. Prognostic value of thallium-201 myocardial perfusion imaging a diagnostic tool comes of age . Circulation. 83:1991;364-381.
4. Shaw L.J., Hachamovitch R., Heller G.V., et al. Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Economics of Noninvasive Diagnosis (END) study group. Am J Cardiol. 86:2000;1-7.
5. 99m sestamibi imaging. J Am Coll Cardiol. 32:1998;57-62.
6. Beller G.A., Zaret B.L. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation. 101:2000;1465-1478.
7. Galassi A.R., Azzarelli S., Tomaselli A., et al. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease. Am J Cardiol. 88:2001;101-106.
8. Gibbons R.J., Balady G.J., Beasley J.W., et al. ACC/AHA guidelines for exercise testing a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing) . J Am Coll Cardiol. 30:1997;260-315.
9. American Society of Nuclear Cardiology. Imaging guidelines for nuclear cardiology procedures, part 2. J Nucl Cardiol 1999;6:G47-84.
10. Thomas G.S., Prill N.V., Majmundar H., et al. Treadmill exercise during adenosine infusion is safe, results in fewer adverse reactions, and improves myocardial perfusion image quality. J Nucl Cardiol. 7:2000;439-446.
11. Lear J, Pratt J, Roberts D, et al. Gamma camera image acquisition, display and processing with the personal microcomputer. Radiology 1990;175:241-5.
12. O'Keefe J.H., Bateman T.M., Ligon R.W., et al. Outcome of medical versus invasive treatment strategies for non-high risk ischemic heart disease. J Nucl Cardiol. 5:1998;28-33.
13. Hachamovitch R., Berman D.S., Shaw L.J., et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death differential stratification for risk of cardiac death and myocardial infarction . Circulation. 97:1998;535-543.
14. Boyne T.S., Koplan B.A., Parsons W.J., et al. Predicting adverse outcome with exercise SPECT technetium-99m sestamibi imaging in patients with suspected and known coronary artery disease. Am J Cardiol. 79:1997;270-274.
15. Thomas G.S., Miyamoto M.I. Is a revision of the warranty in order? J Nucl Cardiol. 30:2003;329-332.
16. United States Life Tables, 1999. National Vital Statistics Reports 2002;6:1-8.
17. Braunwald E. Preface. In: Braunwald E, editor. Heart Disease: A Textbook of Cardiovascular Disease. 5th ed. Philadelphia, PA: W.B. Saunders Company, 1997:xvii.
18. Weiss A.T., Berman D.S., Lew A.S., et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy a marker of severe and extensive disease . J Am Coll Cardiol. 9:1987;752-759.
19. Mazzanti M., Germano G., Kiat H., et al. Identification of severe and extensive coronary artery disease by automatic measurement of transient ischemic dilation of the left ventricle in dual-isotope myocardial perfusion SPECT. J Am Coll Cardiol. 27:1996;1612-1620.
20. Gibbons R.J., Kawalsky D.L. Gated SPECT after myocardial infarction new techniques/old principles . Am J Cardiol. 87:2001;436-438.
21. Sharir T., Germano G., Kang X., et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction . J Nucl Med. 42:2001;831-837.
22. Sharir T., Germano G., Kavanagh P.B., et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation. 100:1999;1035-1042.
23. Kroll D., Farah W., McKendall G.R., et al. Prognostic value of stress-gated Tc-99m sestamibi SPECT after acute myocardial infarction. Am J Cardiol. 87:2001;381-386.
24. Danias P.G., Ahlberg A., Travin M.I., et al. Visual assessment of left ventricular perfusion and function with electrocardiography-gated SPECT has high intraobserver and interobserver reproducibility among experienced nuclear cardiologists and cardiology trainees. J Nucl Cardiol. 9:2002;263-270.
25. Golub R., Ahlberg A., McClellan J.R., et al. Interpretive reproducibility of stress Tc-99m sestamibi tomographic myocardial perfusion imaging. J Nucl Cardiol. 6:1999;257-269.
26. Hachamovitch R., Berman D.S., Kiat H., et al. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol. 80:1997;426-433.
27. Amanullah A.M., Berman D.S., Erel J., et al. Incremental prognostic value of adenosine myocardial perfusion single-photon emission computed tomography in women with suspected coronary artery disease. Am J Cardiol. 82:1998;725-730.
28. Berman D.S., Kang X., Hayes S.W., et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. J Am Coll Cardiol. 41:2003;1125-1133.
29. Pennell D.J., Mavrogeni S.I., Forbat S.M., et al. Adenosine combined with dynamic exercise for myocardial perfusion imaging. J Am Coll Cardiol. 25:1995;1300-1309.
30. Hashimoto A., Palmer E.L., Scott J.A., et al. Complications of exercise and pharmacologic stress tests differences in younger and elderly patients . J Nucl Cardiol. 6:1999;612-619.
31. Elliot M.D., Holly T.A., Leonard S.M., Hendel R.C. Impact of an abbreviated adenosine protocol incorporating adjunctive treadmill exercise on adverse effects and image quality in patients undergoing stress myocardial perfusion imaging. J Nucl Cardiol. 7:2000;584-589.
32. Samady H., Wackers F.J.T., Joska T.M., et al. Pharmacologic stress perfusion imaging with adenosine role of simultaneous low-level treadmill exercise . J Nucl Cardiol. 9:2002;188-196.
33. Kang X., Berman D.S., Lewin H., et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J. 137:1999;949-957.
34. Giri S., Shaw L.J., Murthy D.R., et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation. 105:2002;5-7.
35. Hachamovitch R., Berman D.S., Kiat H., et al. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms an evaluation of incremental prognostic value and cost-effectiveness . Circulation. 105:2002;823-829.
36. Hachamovitch R., Berman D.S., Kiat H., et al. Effective risk stratification using exercise myocardial perfusion SPECT in women gender-related differences in prognostic nuclear testing . J Am Coll Cardiol. 28:1996;34-44.
37. Bateman T.M., O'Keefe J.H., Dong V.M., et al. Coronary angiographic rates after stress single-photon emission computed tomographic scintigraphy. J Nucl Cardiol. 2:1995;217-223.
38. Zellweger M.J., Dubois E.A., Lai S., et al. Risk stratification in patients with remote prior myocardial infarction using rest-stress myocardial perfusion SPECT prognostic value and impact on referral to early catheterization . J Nucl Cardiol. 9:2002;23-32.
39. Levin D.C., Parker L., Intenzo C.M., et al. Recent rapid increase in utilization of radionuclide myocardial perfusion imaging and related procedures 1996-1998 practice patterns . Radiology. 222:2002;144-148.
40. Matsumoto N., Berman D.S., Kavanagh P.B., et al. Quantitative assessment of motion artifacts of a new motion-correction program for myocardial perfusion SPECT. J Nucl Med. 42:2001;687-694.